You are here

Roche

Roche evaluates options for its lung disease drug

Reuters

Mon, 02/26/24 - 05:12 pm

Roche's Xolair reduces reactions to severe food allergies in study

Reuters

Sun, 02/25/24 - 05:36 pm

clinical trials

What did Big Pharma CEOs get paid in 2023?

Medical Marketing and Media

Fri, 02/23/24 - 10:22 am

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel

Fierce Pharma

Thu, 02/22/24 - 11:40 am

Rigel Pharmaceuticals

Blueprint Medicines

FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies

Fierce Pharma

Sun, 02/18/24 - 08:31 pm

Roche-Backed Freenome Continues Industry’s Funding Rally with $254M Raise

BioSpace

Thu, 02/15/24 - 11:16 am

Roche dumps Repare's synthetic lethal drug days after making $40M stitch in Tapistry trial

Fierce Biotech

Tue, 02/13/24 - 11:29 am

Repare Therapeutics

clinical trials

synthetic lethality

Roche to shrink product development team, mainly impacting contractors

Fierce Biotech

Fri, 02/9/24 - 11:10 am

drug development

Roche gets first world okay for PNH drug crovalimab

Pharmaphorum

Thu, 02/8/24 - 10:58 am

Novartis CEO's 2023 pay rises 21% as Roche's helmsman nets $11M in his first year

Fierce Pharma

Mon, 02/5/24 - 11:16 pm

Thomas Schinecker

Roche shares fall on modest 2024 outlook

Reuters

Thu, 02/1/24 - 11:16 am

Roche reports data from Phase III retinal vein occlusion therapy trials

Clinical Trials Arena

Thu, 02/1/24 - 11:15 am

central retinal vein occlusion

Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease

BioPharma Dive

Tue, 01/30/24 - 11:10 am

Cour Pharmaceuticals

autoimmune disease

Bristol Myers Squibb

Hookipa, reeling from Roche’s KRAS cull, lays off 30% of workforce, deprioritizes programs

Fierce Biotech

Mon, 01/29/24 - 11:24 am

Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy

Fierce Biotech

Tue, 01/23/24 - 10:43 am

drug development

autoimmune disease

Roche’s Genentech returns Alzheimer’s assets to AC Immune, cutting 18-year tie to the biotech

Fierce Biotech

Mon, 01/22/24 - 11:19 am

Alzheimer's diseasse

Roche racks up phase 3 TIGIT win, but trial design leaves doubts

Fierce Biotech

Wed, 01/17/24 - 09:33 am

immuno-oncology

clinical trials

Roche is ‘on par’ with Novo, Lilly in GLP-1 race after $2.7B Carmot deal

Medical Devices and Diagnostics Industry

Fri, 01/12/24 - 11:33 am

GLP-1 agonist. obesity

Roche Inks Potential $2B Deal with MOMA, Continues Early January Hot Streak

BioSpace

Fri, 01/5/24 - 09:47 am

MOMA Therapeutics

Pages